Delivery Order SPE2DB24D2010-SPE2DB24FZRY0
- Not listed
- This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products to the Defense Logistics Agency (DLA), a major agency within the Department of Defense responsible for logistics and supply chain management. The $3,413.94 contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on April 15, 2024. The contract has a firm fixed price and is set to expire on April 16, 2024. Amerisourcebergen Drug Corp is a major...
- This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price of $18,023.74 and a completion date of December 20, 2023. The contract was awarded on December 19, 2023 and was not set aside for any specific type of...
- This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products to support government healthcare programs. The $1,479.13 contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This is a firm-fixed-price delivery order with a completion date of February 6, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,084.05 and an ultimate completion date of January 18, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,697.76 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a completion date of July 6, 2023 and was not designated with a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly...
- This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,074.48, is a delivery order with a firm fixed price. It has an ultimate completion date of October 27, 2022. There was no set-aside designation for this contract. Amerisourcebergen Drug Corp...
- This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,629.68 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award has an ultimate completion date of May 7, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly for the...
- This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order with a potential value of $7,859.70 and a performance period ending on February 8, 2024. No set-aside...
- This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The contract, valued at $3,523.32, was awarded on September 14, 2021 with a completion date of September 15, 2021. It is a firm...
- This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products to the Defense Logistics Agency (DLA) by the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $19,144.04 and an ultimate completion date of July 20, 2023. The contract was awarded on July 19, 2023 and is a firm fixed price delivery order. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB24FZRY0Delivery Order
This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price of $15,836.60 and an ultimate completion date of February 23, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated with a set-aside requirement, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.8k | 2/22/24 |